The Serum Institute of India has stockpiled 40 mn-50 mn doses and is adding more every week. Most of these will come to India.
'The US has invoked the Defence Act and banned export of raw materials.' 'This is as good as banning vaccines.'
"I realise that a lot of Indians who have taken Covishield are facing issues with travel to the EU, I assure everyone, I have taken this up at the highest levels and hope to resolve this matter soon, both with regulators and at a diplomatic level with countries," Poonawalla said in a tweet.
"We have requested EU member states to individually consider extending similar exemption to those persons who have taken COVID-19 vaccines in India, that is Covishield and Covaxin, and accept the vaccination certificate issued through the CoWIN portal," said a source.
Addressing a press conference, NITI Aayog member (Health) V K Paul said concerns about adverse effects and serious problems post immunisation, as of now, seem to be unfounded, negligible and insignificant, and stressed that both the vaccines -- Covishield and Covaxin -- are safe.
Dr Malhotra, who has demanded a full safety review into the use of AstraZeneca's Covid vaccine, told PTI Covishield "should never have been rolled out in the country in the first place".
Putting an end to the vaccine certification row, the UK on Thursday announced that Indians, fully vaccinated with Covishield vaccine, will no longer require to undergo quarantine on their arrival in Britain from October 11.
Each vaccination session will cater to a maximum of 100 beneficiaries and the Union Health Ministry has advised states not to organise 'unreasonable numbers of vaccination per site per day'.
India will be within its rights to initiate reciprocal measures if the UK does not address concerns over the new travel rules relating to COVID-19 vaccine certification, foreign secretary Harsh Vardhan Shringla said on Tuesday describing the policy as "discriminatory".
Three big private hospital chains -- Apollo, Fortis and Max -- on Friday announced the launch of Covid-19 immunisation drive for the 18-44 age group at limited centres in the country from May 1 while the Delhi government said it will start the vaccination exercise once it receives doses from the manufacturers.
In a letter to all states and Union territories, the ministry highlighted that under the emergency use authorisation, coronavirus vaccination is indicated only for 18 years and above. If required, COVID-19 vaccine and other vaccines should be separated by an interval of at least 14 days.
Serum Institute of India (SII) and Bharat Biotech have also stopped producing the Covishield and Covaxin vaccines respectively.
The Pune-based vaccine major has entered into a collaboration with the University of Oxford and AstraZeneca to manufacture the vaccine.
The Serum Institute of India has informed the Centre that it will be able to supply around 22 crore doses of Covishield in October as the Union government has announced resuming export of surplus Covid vaccines in the coming fourth quarter under the 'Vaccine Maitri' programme, official sources said.
Ahmedabad-based Zydus Cadila, Bharat Biotech's intra-nasal candidate are among the candidates who got approval from the expert panel to conduct clinical trials, Sohini Das reports.
The volunteer said he had also volunteered 10 years ago for clinical trials for a vaccine against the H1N1 (swine flu) virus.
The Centre is looking to procure around 1 billion syringes between September and December to support the COVID-19 vaccination drive.
British nationals arriving in India, irrespective of their vaccination status, will have to undergo 10 days of mandatory quarantine from October 4 as part of the reciprocal actions initiated by the government following the vaccine certification row between the two countries.
The COVID-19 vaccination drive was successfully conducted on the first day, Additional Secretary in the Union health ministry Manohar Agnani said during a press briefing. Giving an update on COVID-19 vaccination, the health ministry said 3,352 vaccination sessions were held and 1,91,181 beneficiaries vaccinated.
There was the mistaken belief that there was no risk of a second wave anytime soon.
Out of the 447 adverse events following immunisation, only 3 required hospitalisation.
We have applied for marketing authorisation to the EMA through AstraZeneca. We will not sell the vaccine in the EU, said a company source.
Even as the inoculation drive against COVID-19 is set to start in two days, a Maharashtra government official said on Thursday that it will take six to seven months for the vaccine to become available for those who are not in the high-risk category.
The Hyderabad-based Bharat Biotech has fixed the price of its COVID-19 vaccine, Covaxin, at Rs 600 per dose for state governments and at Rs 1,200 per dose for private hospitals. The Pune-based Serum Institute of India, the world's largest vaccine maker in terms of volume, has announced a price of Rs 400 per dose for its COVID-19 vaccine, 'Covishield', for state governments and Rs 600 per dose for private hospitals.
'We seem to be in a situation where we can do little, and nothing needs to be done anyway.'
Maharashtra Chief Minister Uddhav Thackeray on Friday said that whether the fire at the Serum Institute of India (SII) was an accident or sabotage will be known only after the probe gets over.
Raches Ella, project lead, Covid-19 vaccines at Bharat Biotech said in a series of tweets that he was 'surprised' that media and researchers were drawing conclusions based on non-peer reviewed work.
BE's Corbevax is the first such vaccine in India to be approved as a heterologous COVID-19 booster in the country.
AstraZeneca has stressed that patient safety is its "highest priority" and pointed out that regulators around the world "consistently state that the benefits of vaccination outweigh the risks of extremely rare potential side effects".
Of the 1,48,266 beneficiaries who were administered the vaccine on Monday, 8,656 were from Bihar, 1,822 from Assam, 36,888 from Karnataka, 7,070 from Kerala, 6,665 from Madhya Pradesh, 7,628 from Tamil Nadu, 10,352 from Telangana, 11,588 from West Bengal and 3,111 were from Delhi.
Vaccines Covishield and Covaxin work against SARS-CoV-2 variants Alpha, Beta, Gamma and Delta, while effectiveness tests against the Delta Plus variant is ongoing, the government said.
The Bombay high court on Monday said content posted by two individuals and their organisations against vaccine manufacturing major Serum Institute of India (SII) was "prima facie defamatory" and directed them to delete it.
British Prime Minister Boris Johnson and his Indian counterpart Narendra Modi spoke over phone on Monday during which they took stock of India-UK trade and defence talks, opening up of international travel between the two countries and climate action targets in the lead up to the COP26 summit, Downing Street said.
A total of 3,006 session sites across all states and union territories will be virtually connected during the launch at 10.30 am by Prime Minister Narendra Modi and around 100 beneficiaries will be vaccinated at each session site.
World leaders thanked India for its help and support in combating the coronavirus pandemic through "early and meaningful" shipments of COVID-19 vaccine doses, as they addressed the high-level UN General Assembly session this year.
Apart from making efforts to meet the requirements of India, the company is also trying its best to balance the needs of the rest of the world, he added.
The panel also recommended giving approval to Bharat Biotech for carrying out a study on interchangeability of its Covaxin and the under-trial adenoviral intranasal vaccine candidate BBV154, but asked the Hyderabad-based firm to remove the word "interchangeability" from the study title and submit a revised protocol for approval.
They said 37.5 crore of Covishield doses from the Serum Institute of India and 28.5 crore Covaxin doses from Bharat Biotech will be procured by December.
'We are the only country in the world where everybody gets a digital vaccination certificate immediately... Then as we open up, as they did yesterday, which I think is a welcome move, you will have lots and lots of points where people will come in'
According to health ministry officials, over 92 per cent of the adult population have received at least one dose while over 68 per cent have been fully vaccinated.
© 2026 Rediff.com - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances